BCR and B-cell non-Hodgkin lymphoma: Consistent with this, several lines of evidence suggest that TCR activation might be as relevant to TCL pathogenesis as the constitutive B-cell receptor (BCR) signalling is known to promote neoplastic B-cell survival and expansion in B-cell lymphomas.